Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-12-2014 | Laryngology

Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center

Authors: Jesper Brandstorp-Boesen, Ragnhild Sørum Falk, Morten Boysen, Kjell Brøndbo

Published in: European Archives of Oto-Rhino-Laryngology | Issue 12/2014

Abstract

To investigate the changes in the epidemiology of laryngeal squamous cell carcinoma (LSCC) regarding gender, T-stage and subsite distribution, and to identify the potential effect of introducing new therapeutic alternatives for early and advanced stage LSCC. A prospective cohort study of LSCC patients diagnosed and treated at a single tertiary referral center in Norway. Retrospective analysis of prospectively recorded data from 1,616 patients treated for LSCC in all subsites of the larynx during 1983–2010. Females represented an increasing proportion of cases throughout the study (p < 0.01) and presented more often than men with supraglottic cancer (p < 0.01). Marked changes in the distribution of T-stages over time were observed in both early and advanced stage LSCC. T1a glottic tumors constituted 56 % of all early-stage LSCC and were predominantly treated by transoral endoscopic laser surgery. The introduction of chemoradiotherapy for advanced stage LSCC offers a distinct advantage for laryngeal preservation. The increasing proportion of females with LSCC may be explained by changes in smoking habits. The proportion of T1a glottic LSCC gradually increased over time, while T4 supraglottic LSCC became less frequent. Videostroboscopy should be considered mandatory in the diagnosis and follow-up of LSCC. Transoral laser microsurgery is the standard first-line treatment for T1a glottic tumors. Chemoradiotherapy has reduced the number of total laryngectomies and is now regarded as the primary treatment for advanced stage tumors.

Cancer Registry of Norway (2013) Cancer in Norway 2011, Cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, Oslo

Steiner W (1993) Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 14:116–121PubMedCrossRef

Eckel HE, Schneider C, Jungehülsing M, Damm M, Schröder U, Vössing M (1998) Potential role of transoral laser surgery for larynx carcinoma. Lasers Surg Med 23:79–86PubMedCrossRef

Brøndbo K, Boysen M, Natvig K (1997) Laser surgery of laryngeal cancer (T1 glottis). New therapeutic alternative. Tidsskr Nor Laegeforen 117:4070–4071PubMed

The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690CrossRef

Mahler V, Boysen M, Brøndbo K (2010) Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma? Eur Arch Otorhinolaryngol 267:743–750PubMedCrossRef

Sjögren EV, van Rossum MA, Langeveld TP et al (2008) Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg 134:965–972PubMedCrossRef

Sjögren EV, Langeveld TP, Baatenburg de Jong RJ (2008) Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO₂ laser surgery as treatment option. Head Neck 30:1167–1174PubMedCrossRef

Schrijvers ML, van Riel EL, Langendijk JA et al (2009) Higher laryngeal preservation rate after CO₂ laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma. Head Neck 31:759–764PubMedCrossRef

10.

Chen AY, Fedewa S, Zhu J (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985–2007. Arch Otolaryngol Head Neck Surg 137:1017–1024PubMedCrossRef

11.

Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedCrossRef

12.

Vermund H, Boysen M, Brandenburg JH et al (1990) Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx. A comparison of treatment results from two centers. Acta Oncol 29:489–503PubMedCrossRef

13.

Pignon JP, Bourhis J, Domenge C, Designé L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955PubMedCrossRef

14.

Pignon JP, le Maître A, Maillard E, Bourhis J (2009) MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14PubMedCrossRef

15.

Silvestri F, Bussani R, Stanta G, Cosatti C, Ferlito A (1992) Supraglottic versus glottic laryngeal cancer: epidemiological and pathological aspects. ORL J Otorhinolaryngol Relat Spec 54:43–48PubMedCrossRef

16.

Kokoska MS, Piccirillo JF, Haughey BH (1995) Gender differences in cancer of the larynx. Ann Otol Rhinol Laryngol 104:419–424PubMedCrossRef

17.

Mäkitie A, Pukander J, Raitiola H et al (1999) Changing trends in the occurrence and subsite distribution of laryngeal cancer in Finland. Eur Arch Otorhinolaryngol 256:277–279PubMedCrossRef

18.

Pantel M, Guntinas-Lichius O (2012) Laryngeal carcinoma: epidemiology, risk factors and survival. HNO 60:32–40PubMedCrossRef

19.

Raitiola H, Pukander J, Laippala P (1999) Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 119:847–851PubMedCrossRef

20.

Lund KE, Lund M, Bryhni A (2009) Tobacco consumption among men and women 1927–2007. Tidsskr Nor Laegeforen 129:1871–1874PubMedCrossRef

21.

De Stefani E, Boffetta P, Deneo-Pellegrini H et al (2004) Supraglottic and glottic carcinomas: epidemiologically distinct entities? Int J Cancer 112:1065–1071PubMedCrossRef

22.

Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C (2003) Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol Biomarkers Prev 12:514–517PubMed

23.

Statistics Norway. Smoking habits 2012. Available at http://www.ssb.no/english/subjects/03/01/royk_en/. Accessed 20 Jan 2014

24.

Stephenson WT, Barnes DE, Holmes FF, Norris CW (1991) Gender influences subsite of origin of laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 117:774–778PubMedCrossRef

25.

Yang PC, Thomas DB, Daling JR, Davis S (1989) Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol 42:755–758PubMedCrossRef

26.

Menvielle G, Luce D, Goldberg P, Bugel I, Leclerc A (2004) Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case-control study in France. Eur J Cancer Prev 13:165–172PubMedCrossRef

27.

Hashibe M, Boffetta P, Zaridze D et al (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820PubMedCrossRef

28.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90:1–636

29.

Mork J, Lie AK, Glattre E et al (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131PubMedCrossRef

30.

Hannisdal K, Schjølberg A, De Angelis PM, Boysen M, Clausen OP (2010) Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway. Acta Otolaryngol 130:293–299PubMedCrossRef

31.

Genden EM, Sambur IM, de Almeida JR et al (2013) Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol 270:405–416PubMedCrossRef

32.

Joint National Capacit Assessmant on the Implementation of Effective Tobacco Control Policies in Norway, WHO April 2010. http://www.regjeringen.no/upload/HOD/CapacityAssesmReportNORWAY.pdf

33.

Thurnher D, Erovic BM, Frommlet F et al (2008) Challenging a dogma–surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy. Eur J Surg Oncol 34:692–698PubMedCrossRef

34.

Bailey BJ (1991) Beyond the ‘new’ TNM classification. Arch Otolaryngol Head Neck Surg 117:369–370PubMedCrossRef

35.

Ferlito A, Harrison DF, Bailey BJ, DeSanto LW (1995) Are clinical classifications for laryngeal cancer satisfactory? Ann Otol Rhinol Laryngol 104:741–747PubMedCrossRef

36.

Ferlito A, Rinaldo A (2008) The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol 265:1441–1443PubMedCrossRef

37.

Takes RP, Rinaldo A, Silver CE et al (2010) Future of the TNM classification and staging system in head and neck cancer. Head Neck 32:1693–1711PubMedCrossRef

38.

Ambrosch P, Fazel A (2011) Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 10:Doc02. doi: 10.3205/cto000075

39.

Rigby MH, Reynolds LF, Hart RD, Trites JR, Brown T, Mark Taylor S (2012) T2 glottic carcinoma: analysis of recurrences in 36 cases undergoing primary transoral laser microsurgery resection. J Otolaryngol Head Neck Surg 41(Suppl 1):S85–S89PubMed

40.

Suárez C, Rodrigo JP, Silver CE et al (2012) Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. Head Neck 34:1028–1035PubMedCrossRef

41.

Ansarin M, Planicka M, Rotundo S et al (2007) Endoscopic carbon dioxide laser surgery for glottic cancer recurrence after radiotherapy: oncological results. Arch Otolaryngol Head Neck Surg 133:1193–1197PubMedCrossRef

42.

Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC (2007) Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg 136:900–906PubMedCrossRef

43.

Stoeckli SJ, Schnieper I, Huguenin P, Schmid S (2003) Early glottic carcinoma: treatment according patient’s preference? Head Neck 25:1051–1056PubMedCrossRef

44.

Higgins KM, Shah MD, Ogaick MJ, Enepekides D (2009) Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 38:603–612PubMed

45.

Forastiere AA, Zhang Q, Weber RS et al (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31:845–852PubMedCentralPubMedCrossRef

Title: Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center
Authors: Jesper Brandstorp-Boesen
Ragnhild Sørum Falk
Morten Boysen
Kjell Brøndbo
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 12/2014
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-014-3100-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2014

Brush biopsy with DNA-image cytometry: a useful and noninvasive method for monitoring malignant transformation of potentially malignant oral disorders

Critical analysis of recurrences of esthesioneuroblastomas: can we prevent them?

Clinical characteristics of spontaneous cholesteatoma of the external auditory canal in children comparing with cholesteatoma in adults

Multiple chemical sensitivity worsens quality of life and cognitive and sensorial features of sense of smell

KTP laser stapedotomy with a self-crimping, thermal shape memory Nitinol piston: follow-up study reporting intermediate-term hearing

The radiological diagnosis of fenestral otosclerosis: the utility of histogram analysis using multidetector row CT